Search results
Updates on Chronic Coronary Syndrome
Author(s):
Filippo Gurgoglione
,
Giampaolo Niccoli
Added:
1 year ago
Editorial
Author(s):
William Herrington
Added:
1 year ago
Long-term cardio-renal outcomes investigating empagliflozin (Boehringer Ingelheim) on kidney disease progression (KDP) or cardiovascular death in patients with pre-existing chronic kidney disease.In this short interview, Prof William Herrington (Nuffield Department of Population Health, University of Oxford, Oxford, UK) discusses the findings from EMPA-KIDNEY (NCT03594110).EMPA-KIDNEY is an…
View more
Non-invasive Coronary Functional Tests in ANOCA
Author(s):
Nello Cambise
,
Angelo Giuseppe Marino
,
Fabio De Benedetto
,
et al
Added:
1 month ago
Original Research
Author(s):
Federica Piani
,
Lorenzo Annesi
,
Claudio Borghi
Added:
9 months ago
Author(s):
Gaetano Antonio Lanza
Added:
9 months ago
Management of Left Main Coronary Artery Disease
Author(s):
Gabriel Torres-Ruiz
,
Nuria Mallofré-Vila
,
Paola Rojas-Flores
,
et al
Added:
2 years ago
Review Article
Author(s):
Armin Arbab-Zadeh
,
Michelle Graham
,
Hector M Garcia-Garcia
,
et al
Added:
6 months ago
Author(s):
William E Boden
,
Juan Carlos Kaski
,
C Noel Bairey Merz
,
et al
Added:
10 months ago
Obesity and CKD: The Dual Epidemic in Cardiovascular Health
Author(s):
Christopher Henry Grant
,
Samira Bell
Added:
4 months ago
Review Article
Author(s):
Giuseppe Rosano
,
Harriette Van Spall
Added:
2 years ago
ESC 23 – Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Prof Giuseppe Rosano (St George’s Hospitals NHS Trust University of London, UK), President of HFA to distil the key messages from the 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
Prof Rosano summarises the retained ejection fraction…
View more